Where could NUVL trade next? Consensus target price: $130.
Get informed when a big investor buys or sells
+ Follow$123.96
13 analysts in the last 4 months
High: $189 | Low: $122.85
No recommendations in the last 4 months.
Nuvalent (NUVL) currently reports a target price of $130. Use the charts on this page to explore Nuvalent's target price history and peer comparisons.
Analysts' average 12-month price target for Nuvalent is $130, about 6.5% upside from the current share price of $123.96. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $130, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nuvalent, and consider following NUVL for alerts when major investors trade the stock.
Nuvalent is classified in the Healthcare sector. On target price, it currently shows $130. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NUVL with unrelated industries.